Skip to Content

RP 134 (Fenofibrate (Micronized) 134 mg)

Pill with imprint RP 134 is Blue, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Rhodes Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RP 134

Fenofibrate (micronized) 134 mg RP 134

Fenofibrate (Micronized)

Imprint
RP 134
Strength
134 mg
Color
Blue
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Rhodes Pharmaceuticals
Manufacturer
Teva Canada Limited
National Drug Code (NDC)
42858-0134
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k25, corn starch, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, FD&C Blue No. 1, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "RP 134"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.